Concepedia

Miroslav Boudný

MB

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2019

Affiliations

Central European Institute of Technology – Masaryk University(Current)

University Hospital Brno

Masaryk University

Central European Institute of Technology

St. Anne's University Hospital Brno

Miroslav Boudný is an author at Central European Institute of Technology – Masaryk University specializing in checkpoint kinase inhibition, pharmacology, and replication stress arrest.

ORCID

Publications per year

2019–2024

3

Publications

3

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells

Miroslav Boudný, Jana Zemanová, Prashant Khirsariya et al. · Haematologica · 2019 · 25 citations · Full text

, , +16

Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities

Rahul Deb, Marcelo D. T. Torres, Miroslav Boudný et al. · Journal of Medicinal Chemistry · 2024 · 21 citations · Full text

, , +17

Synthesis and Profiling of Highly Selective Inhibitors of Methyltransferase DOT1L Based on Carbocyclic C-Nucleosides

Prashant Khirsariya, Patrik Pospíšil, Lukáš Maier et al. · Journal of Medicinal Chemistry · 2022 · 11 citations · Full text

, , +11

1–3 of 3